Publication Information

{'id': 'https://openalex.org/W4225588595', 'doi': 'https://doi.org/10.1097/ju.0000000000002526.02', 'title': 'PD07-02 TARGETING WNT5A/FZD2 SIGNALING OVERCOMES RESISTANCE TO ENZALUTAMIDE IN ADVANCED PROSTATE CANCER', 'display_name': 'PD07-02 TARGETING WNT5A/FZD2 SIGNALING OVERCOMES RESISTANCE TO ENZALUTAMIDE IN ADVANCED PROSTATE CANCER', 'publication_year': 2022, 'publication_date': '2022-04-07', 'ids': {'openalex': 'https://openalex.org/W4225588595', 'doi': 'https://doi.org/10.1097/ju.0000000000002526.02'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/ju.0000000000002526.02', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5003405281', 'display_name': 'Shu Ning', 'orcid': 'https://orcid.org/0000-0002-3341-394X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Shu Ning', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101592945', 'display_name': 'Chengfei Liu', 'orcid': 'https://orcid.org/0000-0002-2452-8788'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Chengfei Liu', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5012734277', 'display_name': 'Wei Lou', 'orcid': 'https://orcid.org/0000-0002-4688-1216'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Wei Lou', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007026296', 'display_name': 'Alan P. Lombard', 'orcid': 'https://orcid.org/0000-0002-0266-4420'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Alan Lombard', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009880021', 'display_name': 'Leandro S. D’Abronzo', 'orcid': 'https://orcid.org/0000-0003-4555-4245'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': "Leandro D'Abronzo", 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101154331', 'display_name': 'Aiming Yu', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Aiming Yu', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5010640380', 'display_name': 'Christopher H. Evans', 'orcid': 'https://orcid.org/0000-0001-5532-2347'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Christopher Evans', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5048369552', 'display_name': 'Allen C. Gao', 'orcid': 'https://orcid.org/0000-0002-5966-9038'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Allen Gao', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.253, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.526625, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 60, 'max': 70}, 'biblio': {'volume': '207', 'issue': 'Supplement 5', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12505', 'display_name': 'Peptidase Inhibition and Analysis', 'score': 0.9744, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.961, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.976015}, {'id': 'https://openalex.org/keywords/antiandrogens', 'display_name': 'Antiandrogens', 'score': 0.48528573}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.976015}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.82987106}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7323295}, {'id': 'https://openalex.org/C137620995', 'wikidata': 'https://www.wikidata.org/wiki/Q155769', 'display_name': 'Wnt signaling pathway', 'level': 3, 'score': 0.70012367}, {'id': 'https://openalex.org/C107300179', 'wikidata': 'https://www.wikidata.org/wiki/Q41797887', 'display_name': 'Frizzled', 'level': 4, 'score': 0.61455935}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.60616565}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.53728604}, {'id': 'https://openalex.org/C2910016293', 'wikidata': 'https://www.wikidata.org/wiki/Q574820', 'display_name': 'Antiandrogens', 'level': 5, 'score': 0.48528573}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.46442997}, {'id': 'https://openalex.org/C62478195', 'wikidata': 'https://www.wikidata.org/wiki/Q828130', 'display_name': 'Signal transduction', 'level': 2, 'score': 0.4333273}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.35150626}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.32646662}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.1314455}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.09870878}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/ju.0000000000002526.02', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.71, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4207033132', 'https://openalex.org/W2523742327', 'https://openalex.org/W2081949986', 'https://openalex.org/W2080509277', 'https://openalex.org/W2051803999', 'https://openalex.org/W2018448892', 'https://openalex.org/W2017632960', 'https://openalex.org/W2006555393', 'https://openalex.org/W1972875962', 'https://openalex.org/W17572718'], 'abstract_inverted_index': {'You': [0], 'have': [1], 'accessJournal': [2], 'of': [3, 134, 157, 196, 207, 264, 290, 335, 346, 394, 441, 453, 459], 'UrologyCME1': [4], 'May': [5], '2022PD07-02': [6], 'TARGETING': [7], 'WNT5A/FZD2': [8], 'SIGNALING': [9], 'OVERCOMES': [10], 'RESISTANCE': [11], 'TO': [12], 'ENZALUTAMIDE': [13], 'IN': [14], 'ADVANCED': [15], 'PROSTATE': [16], 'CANCER': [17], 'Shu': [18, 35, 496], 'Ning,': [19], 'Chengfei': [20, 44, 503], 'Liu,': [21], 'Wei': [22, 53, 510], 'Lou,': [23], 'Alan': [24, 62, 517], 'Lombard,': [25], 'Leandro': [26, 71, 524], "D'Abronzo,": [27], 'Aiming': [28, 80, 531], 'Yu,': [29], 'Christopher': [30, 89, 538], 'Evans,': [31], 'and': [32, 98, 203, 231, 244, 269, 295, 303, 308, 316, 330, 338, 342, 357, 370, 373, 400, 407, 425, 429, 443, 473, 492], 'Allen': [33, 99, 545], 'Gao': [34, 101, 546], 'NingShu': [36], 'Ning': [37, 497], 'More': [38, 47, 56, 65, 74, 83, 92, 102, 498, 505, 512, 519, 526, 533, 540, 547], 'articles': [39, 48, 57, 66, 75, 84, 93, 103, 499, 506, 513, 520, 527, 534, 541, 548], 'by': [40, 49, 58, 67, 76, 85, 94, 104, 468, 487, 500, 507, 514, 521, 528, 535, 542, 549], 'this': [41, 50, 59, 68, 77, 86, 95, 105, 501, 508, 515, 522, 529, 536, 543, 550], 'author': [42, 51, 60, 69, 78, 87, 96, 106, 502, 509, 516, 523, 530, 537, 544, 551], ',': [43, 52, 61, 70, 79, 88, 97], 'LiuChengfei': [45], 'Liu': [46, 504], 'LouWei': [54], 'Lou': [55, 511], 'LombardAlan': [63], 'Lombard': [64, 518], "D'AbronzoLeandro": [72], "D'Abronzo": [73, 525], 'YuAiming': [81], 'Yu': [82, 532], 'EvansChristopher': [90], 'Evans': [91, 539], 'GaoAllen': [100], 'View': [107], 'All': [108, 553], 'Author': [109], 'Informationhttps://doi.org/10.1097/JU.0000000000002526.02AboutPDF': [110], 'ToolsAdd': [111], 'to': [112, 146, 199, 210, 284, 297, 323, 382, 403], 'favoritesDownload': [113], 'CitationsTrack': [114], 'CitationsPermissionsReprints': [115], 'ShareFacebookLinked': [116], 'InTwitterEmail': [117], 'Abstract': [118], 'INTRODUCTION': [119], 'AND': [120], 'OBJECTIVE:': [121], 'Androgen': [122], 'receptor': [123, 177, 187], '(AR)': [124], 'blockade': [125], 'using': [126, 236, 359, 387], 'antiandrogens': [127], 'is': [128, 161, 180], 'a': [129, 154], 'mainstay': [130], 'for': [131, 178], 'the': [132, 174, 181, 194, 205, 333, 344, 350, 388, 392, 432], 'treatment': [133, 201], 'castration': [135, 215], 'resistant': [136, 216, 226, 318, 396, 408], 'prostate': [137, 189, 217, 363, 397, 426], 'cancer': [138, 364, 398, 427], '(CRPC).': [139], 'Unfortunately,': [140], 'drug': [141], 'resistance': [142, 213, 424, 448], 'occurs': [143], 'frequently': [144], 'due': [145], 'mechanisms': [147], 'that': [148, 420], 'are': [149, 310], 'not': [150, 445], 'completely': [151], 'understood.': [152], 'Wnt5a,': [153, 179], 'representative': [155], 'ligand': [156], 'non-canonical': [158, 185, 197, 265, 351, 433], 'Wnt': [159, 186, 266, 352], 'signaling,': [160, 267], 'expressed': [162], 'in': [163, 188, 214, 224, 248, 301, 304, 313, 349, 405, 414, 455], 'circulating': [164], 'tumor': [165, 293, 412], 'cells': [166, 257, 321, 381, 399, 402], 'from': [167], 'CRPC': [168, 314, 409, 456], 'patients': [169, 315], 'treated': [170], 'with': [171, 258, 376], 'enzalutamide.': [172], 'FZD2,': [173, 444], 'cognate': [175], 'frizzled': [176], 'most': [182], 'commonly': [183], 'co-upregulated': [184, 312], 'cancer.': [190, 218], 'Here': [191], 'we': [192], 'determine': [193], 'contribution': [195], 'Wnt5a/FZD2': [198, 209, 220, 286, 421, 434], 'enzalutamide': [200, 225, 298, 317, 383, 395, 404, 423, 454], 'resistance,': [202], 'explore': [204], 'potential': [206], 'targeting': [208], 'overcome': [211], 'antiandrogen': [212], 'METHODS:': [219], 'expression': [221, 233, 263, 341], 'was': [222, 252, 282, 299], 'examined': [223], 'C4-2B': [227, 255, 319, 325, 379], 'MDVR': [228, 256, 320, 380], 'cells.': [229, 326], 'Wnt5a': [230, 279, 307, 329, 356, 372, 386, 442], 'FZD2': [232, 309, 331, 358, 374], 'were': [234, 246, 273], 'modulated': [235], 'specific': [237, 360], 'siRNAs.': [238], 'Cell': [239], 'growth,': [240, 366], 'colony': [241, 367], 'formation,': [242, 368], 'migration': [243, 369], 'invasion': [245], 'determined': [247], 'vitro.': [249], 'RNA': [250, 277], 'sequencing': [251], 'analyzed': [253], 'on': [254, 292], 'WNT5a/FZD2': [259], 'knocked': [260], 'down;': [261], 'gene': [262], 'AR': [268, 337, 339], 'AR-V7': [270], 'signature': [271], 'genes': [272, 347], 'analyzed.': [274], 'A': [275], 'novel': [276], 'bioengineered': [278, 389], 'siRNA': [280, 377], '(tRNA-siWnt5A)': [281], 'developed': [283], 'target': [285], 'signaling.': [287], 'The': [288], 'effect': [289], 'tRNA-siWnt5a': [291], 'growth': [294, 393, 413], 'sensitivity': [296], 'evaluated': [300], 'vitro': [302], 'vivo.': [305, 415], 'RESULTS:': [306], 'highly': [311], 'compared': [322], 'parental': [324], 'Knocking': [327], 'down': [328], 'abrogates': [332], 'increase': [334], 'full-length': [336], 'variant': [340], 'diminishes': [343], 'enrichment': [345], 'involved': [348], 'signaling': [353], 'pathway.': [354], 'Blocking': [355], 'siRNAs': [361], 'suppresses': [362, 436], 'cell': [365], 'invasion.': [371], 'knockdown': [375], 'resensitized': [378, 401], 'treatment.': [384], 'Targeting': [385, 431], 'tRNA-siWnt5A': [390], 'inhibited': [391], 'vitro,': [406], 'LuCaP35CR': [410], 'PDX': [411], 'CONCLUSIONS:': [416], 'Our': [417], 'studies': [418], 'suggest': [419], 'confers': [422], 'survival': [428], 'proliferation.': [430], 'pathway': [435], 'tumors': [437], 'expressing': [438], 'high': [439], 'level': [440], 'only': [446], 'overcoming': [447], 'but': [449], 'potentiating': [450], 'anti-tumor': [451], 'effects': [452], 'patients.': [457], 'Source': [458], 'Funding:': [460], 'CA250082,': [461], 'CA': [462], '225836,': [463], 'DOD': [464], 'PC180180': [465], '©': [466], '2022': [467, 486], 'American': [469, 488], 'Urological': [470, 489], 'Association': [471, 490], 'Education': [472, 491], 'Research,': [474, 493], 'Inc.FiguresReferencesRelatedDetails': [475], 'Volume': [476], '207Issue': [477], 'Supplement': [478], '5May': [479], '2022Page:': [480], 'e98': [481], 'Advertisement': [482, 554], 'Copyright': [483], '&': [484], 'Permissions©': [485], 'Inc.MetricsAuthor': [494], 'Information': [495], 'Expand': [552], 'PDF': [555], 'DownloadLoading': [556], '...': [557]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4225588595', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}], 'updated_date': '2024-12-19T13:35:27.533319', 'created_date': '2022-05-05'}